002390.KO Handok

Healthcare Pharmaceuticals Korea Stock Exchange
8,210 KRW
Close of Nov 4, 2026
6,460 11,943
Market cap
KRW 107B
P/E
-
P/B
0.42x
ROE
-16.8%
Dividend yield
2.58%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 002390.KO undervalued?

Graham number

The Graham number of Handok cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Handok fundamental analysis

No fundamental analysis for Handok yet.

Handok stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Handok

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition pr…

Full company profile